Immune privilege and the skin

Current Directions in Autoimmunity

Volumn 10, Issue , 2008, Pages 27-52

  Ito, T ^a   Meyer, K ^b   Ito, N ^a   Paus, R ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOSUPPRESSIVE AGENT;

ALOPECIA AREATA; ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; GENE EXPRESSION REGULATION; HAIR FOLLICLE; HUMAN; IMMUNOLOGY; METABOLISM; NAIL; NATURAL KILLER CELL; REVIEW;

ALOPECIA AREATA; ANIMALS; ANTIGEN-PRESENTING CELLS; GENE EXPRESSION REGULATION; HAIR FOLLICLE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; NAILS; ORGAN SPECIFICITY;

EID: 49049119380     PISSN: 14222132     EISSN: 16622936     Source Type: Book Series    
DOI: 10.1159/000131412     Document Type: Review

References (93)

1. Greene HSN: The use of the mouse eye in transplantation experiments. Cancer Res 1947;7:491-501.
2. Andrew L, David M, Munn H: Immune privilege: a recurrent theme in immunoregulation? Immunol Rev 2006;213:5-11.
3. Billingham RE, Boswell T: Studies on the problem of corneal homografts. Proc R Soc Lond B Biol Sci 1953;141:392-406.
4. Head JR, Billingham RE: Immunologically privileged sites in transplantation immunology and oncology. Perspect Biol Med 1985;29:115-131.
5. Streilein JW: Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 1993;5:428-432.
6. Brent L: A History of Transplantation Immunology. San Diego, Academic Press, 1997.
7. Janeway CA, Travers P, Walport M, Shlomchik MJ: Autoimmunity and transplantation; in Janeway CA (ed): Immunobiology. New York, Garland Publishing, 2001, pp 557-612.
8. Niederkorn JY: Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 2002;22:13-46.
9. Melllor AL, Munn DH: Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Ann Rev Immunol 2000;18:367-391.
10. Erlebacher A: Why isn't the fetus rejected? Curr Opin Immunol 2001;13:590-593.
11. Paus R, Nickoloff BJ, Ito T: A 'hairy' privilege. Trends Immunol 2005;26:32-40.
12. Ito T, Ito N, Saathoff M, Stampachiacchiere B, Bettermann A, Bulfone-Paus S, Takigawa M, Nickoloff BJ, Paus R: Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 2005;125:1139-1148.
13. Bruno R, Sabater L, Sospedra M, Ferrer-Francesch X, Escudero D, Martinez-Caceres E, Pujol-Borrell R: Multiple sclerosis candidate autoantigens except myelin oligodendrocyt glycoprotein are transcribed in human thymus. Eur J Immunol 2002;32:2737-2747.
14. Filippini A, Riccioli A, Padula F, Lauretti P, D'Alessio A, De Cesaris P, Gandini L, Lenzi A, Ziparo E: Control and impairment of immune privilege in the testis and in semen. Hum Reprod Update 2001;7:444-449.
15. Lobo-Yeo A, Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D: Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease. Hepatology 1990;12:224-232.
16. Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F: Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 1988;8:449-454.
17. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR: HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002;32:311-315.
18. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-1193.
19. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P: Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003;4:1206-1212.
20. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H: A critical role for murine complement regular Crry in fetomaternal tolerance. Science 2000;287:498-501.
21. Hobbs NK, Bondareva AA, Barnett S, Capecchi MR, Schmidt EE: Removing the vertebratespecific TBP N terminus disrupts placental β2m-dependent interactions with the maternal immune system. Cell 2002;12:110:43-54.
22. Paul W: Fundamental Immunology. Philadelphia, Lippincott-Raven, 1999, p 49.
23. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B: T cell awareness of paternal alloantigens during pregnancy. Science 1995;270:630-633.
24. Meyer KV, Kloepper JE, Tiede S, Paus R: The human hair follicle bulge: immunohistological examination of potential stem cell-niche element, and further indications that it displays relative immune privilege. J Invest Dermatol 2007;127:A198.
25. Paus R, Peker S: Biology of hair and nails; in Bolognia JL, Jorizzo J, Rapini R (eds): Dermatology. London, Elsevier Science, 2003, vol 1, pp 1007-1032.
26. Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 1999;341:491-498.
27. Cotsarelis G, Millar SE: Towards a molecular understanding of hair loss and its treatment. Trends Mol Med 2001;7:293-301.
28. Lang KS, Caroli CC, Muhm A, Wernet D, Moris A, Schittek B, Knauss-Scherwitz E, Stevanovic S, Rammensee HG, Garbe C: HLA-A2 restricted, melanocyte-specific CD8 T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol 2001;116:891-897.
29. Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V: High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998;188:1203-1208.
30. Yagi H, Hashizume H, Horibe T, Yoshinari Y, Hata M, Ohshima A, Ito T, Takigawa M, Shibaki A, Shimizu H, Seo N: Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization. Cancer Res 2006;66:10136-10144.
31. Barnhill RL, Llewellyn K: Benign melanocyte neoplasms; in Bolognia JL, Jorizzo JL, Rapini RP (eds): Dermatology. London, Elsevier Science, 2003, pp 1757-1787.
32. Gilhar A, Kam Y, Assy B, Kalish RS: Alopecia areata induced in C3H/HeJ mice by interferon-γ: evidence for loss of immune privilege. J Invest Dermatol 2005;124:288-289.
33. Gilhar A, Kalish RS: Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006;5:64-69.
34. Billingham RE, Silvers WK: A biologist's reflections on dermatology. J Invest Dermatol 1971;57:227-240.
35. Billingham RE: The immunobiology of tissue transplantation. Int Dent J 1971;21:478-487.
36. Paus R, Stenn KS, Link RE: Telogen skin contains an inhibitor of hair growth. Br J Dermatol 1990;122:777-778.
37. Hofmann U, Tokura Y, Rückert R, Paus R: The anagen hair cycle induces systemic immunosuppression of contact hypersensitivity in mice. Cell Immunol 1998;184:65-73.
38. Tokura Y, Hofmann U, Müller-Röver S, Paus R, Wakita H, Yagi H, Seo N, Furukawa F, Takigawa M: Spontaneous hair follicle cycling may influence the development of murine contact photosensitivity by modulating keratinocyte cytokine production. Cell Immunol 1997;178:172-179.
39. Welker P, Foitzik K, Bulfone-Paus S, Henz BM, Paus R: Hair cycle-dependent changes in the gene expression and protein content of transforming factor β1 and ν3 in murine skin. Arch Dermatol Res 1997;289:554-557.
40. Slominski A, Botchkareva NV, Botchkarev VA, Chakraborty A, Luger T, Uenalan M, Paus R: Hair cycle-dependent production of ACTH in mouse skin. Biochim Biophys Acta 1998;1448:147-152.
41. Harrist TJ, Ruiter DJ, Mihm MC Jr, Bhan AK: Distribution of major histocompatibility antigens in normal skin. Br J Dermatol 1983;109:623-633.
42. Bröcker EB, Echternacht-Happle K, Hamm H, Happle R: Abnormal expression of class I and class II major histocompatibility antigen in alopecia areata. J Invest Dermatol 1987;88:564-568.
43. Westgate GE, Craggs RI, Gibson WT: Immune privilege and hair growth. J Invest Dermatol 1991;97:417-420.
44. Paus R, Eichmüller S, Hofmann U, Czarnetzki BM, Robinson P: Expression of classical and nonclassical MHC class I antigens in murine hair follicles. Br J Dermatol 1994;131:177-183.
45. Christoph T, Müller-Röver S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, Rückert R, Paus R: The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000;142:862-873.
46. Paus R, Hofmann U, Eichmüller S, Czarnetzki BM: Distribution and changing density of - T cells in murine skin during the induced hair cycle. Br J Dermatol 1994;130:281-289.
47. Stenn KS, Paus R: Control of hair follicle cycling. Physiol Rev 2001;81:449-494.
48. Foitzik K, Lindner G, Müller-Röver S, Maurer M, Botchkareva N, Botchkarev V, Handjiski B, Metz M, Hibino T, Soma T, Dotto GP, Paus R: Control of murine hair follicle regression (catagen) by TGF-b1 in vivo. FASEB J 2000;14:752-760.
49. Slominski A, Wortsman J, Mazurkiewicz JE, Matsuoka L, Dietrich J, Lawrence K, Gorbani A, Paus R: Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993;122:658-666.
50. Slominski A, Wortsman J, Luger T, Paus R, Solomon S: Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000;80:979-1020.
51. Paus R, Botchkarev VA, Botchkareva NV, Mecklenburg L, Luger T, Slominski A: The skin POMC system (SPS): leads and lessons from the hair follicle. Ann NY Acad Sci 1999;885:350-363.
52. Botchkarev VA, Botchkareva NV, Slominski A, Roloff B, Luger T, Paus R: Developmentally regulated expression of α-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann NY Acad Sci 1999;885:433-439.
53. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, Straub RH, Paus R: Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005;19:1332-1334.
54. Foitzik K, Spexard T, Nakamura M, Halsner U, Paus R: Towards dissecting the pathogenesis of retinoid-induced hair loss: all-trans retinoic acid induces premature hair follicle regression (catagen) by upregulation of transforming growth factor-β2 in the dermal papilla. J Invest Dermatol 2005;124:1119-1126.
55. Ohyama M, Terunuma A, Tock CL, Radomovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC: Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006;116:249-260.
56. Morris JR, Liu Y, Marles L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA, Cotsarelis G: Capturing and profiling adult hair follicle stem cells. Nat Biotech 2004;22:411-417.
57. Gielen V, Schmitt D, Thivolet J: HLA class I antigen (heavy and light chain) expression by Langerhans cells and keratinocytes of the normal human epidermis: ultrastractual quantitation using immunogold labelling procedure. Arch Dermatol Res 1998;280:131-136.
58. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N: HLA-G-mediated inhibition on antigen-specific cytotoxic T lymphocytes. Int Immunol 1999;11:1351-1356.
59. Paus R, van der Veen C, Eichmüller S, Kopp T, Hagen E, Müller-Röver S, Hofmann U: Generation and cyclic remodeling of the hair follicle immune system in mice. J Invest Dermatol 1998;111:7-18.
60. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R: Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004;164:623-634.
61. Pamer E, Cresswell P: Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998;16:323-358.
62. Momburg F, Roelse J, Hammerling GJ, Neefjes JJ: Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 1994;179:1613-1623.
63. Rückert R, Hofmann U, van der Veen C, Bulfone-Paus S, Paus R: MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 1998;111:25-30.
64. Long EO: Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
65. Vivier E, Tomasello E, Paul P: Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr Opin Immunol 2002;14:306-311.
66. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729.
67. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH: An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999;285:730-732.
68. Ito T, Saathoff M, Nickoloff BJ, Takigawa M, Paus R: Novel aspects of hair follicle immune privilege and their relevance to alopecia areata. J Invest Dermatol 2005;124:A103.
69. Slominski A, Paus R, Mazurkiewicz J: Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 1992;48:50-54.
70. Cooper A, Robinson SJ, Pickard C, Jackson CL, Friedmann PS, Healy E: α-Melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 2005;175:4806-4813.
71. Cerwenka A, Swain SL: GF-β1: immunosuppressant and viability factor for T lymphocyte. Microbes Infect 1999;1:1291-1296.
72. Niederkorn JY: Mechanisms of immune privilege in the eye and hair follicle. J Invest Dermatol Symp Proc 2003;8:168-172.
73. Streilein JW: Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nature Rev Immunol 2003;3:879-889.
74. Dawber R, Fenton DA: Infections and infestations; in Dawber R (ed): Diseases of the Hair and Scalp, ed 3 (rev). Oxford, Blackwell Science, 1997, pp 418-460.
75. Hermes B, Paus R: Scar forming alopecia: comments in classification, differenciatial diagnosis and pathobiology. Hautarzt 1998;49:462-472.
76. Paus R, Christoph T, Müller-Röver S: Immunology of the hair follicle: a short journey into terra incognita. J Invest Dermatol Symp Proc 1999;4:226-234.
77. Paus R, Slominski A, Czarnetzki BM: Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1994;66:541-554.
78. de Berker DAR, Baran R, Dawber RPR: The nail in dermatological diseases; in Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti A (eds): Diseases of the Nails and their Management. Oxford, Blackwell Science, 2001, pp 172-222.
79. Hanno R: Inflammatory reactions of the nail; in Farmer ER, Hood AF (eds): Pathology of the Skin. New York, McGraw-Hill, 2000, pp 870-875.
80. Tosti A, Baran R, Dawber RPR: The nail in systemic diseases and drug-induced changes; in Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti A (eds): Diseases of the Nails and their Management. Oxford, Blackwell Science, 2001, pp 223-229.
81. Tosti A, Piraccini BM: Biology of nails; in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds): Fitzpatrick's Dermatology in General Medicine. New York, McGraw-Hill, 2003, pp 159-163.
82. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS: Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998;101:62-67.
83. Sperling LC, Lupton GP: Histopathology of non-scarring alopecia. J Cutan Pathol 1995;22:97-114.
84. Whiting DA: Histopathologic features of alopecia areata: a new look. Arch Dermatol 2003;139:1555-1559.
85. Todes-Taylor N, Turner R, Wood GS, Stratte PT, Morhenn VB: T cell subpopulations in alopecia areata. J Am Acad Dermatol 1984;11:216-223.
86. Hordingsky MK: Alopecia areata; in Olsen EA (ed): Disorders of Hair Growth. New York, McGraw-Hill, 2003, pp 239-274.
87. Slominski A, Paus R: Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 1993;101(suppl 1):90S-97S.
88. Freyschmidt-Paul P, McElwee KJ, Hoffmann R, Sundberg JP, Vitacolonna M, Kissling S, Zoller M: Interferon-γ-deficient mice are resistant to the development of alopecia areata. Br J Dermatol 2006;155:515-521.
89. Ito T, Ito N, Saathoff M, Bettermann A, Takigawa M, Paus R: Interferon-γ is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol 2005;152:623-631.
90. Luger TA, Scholzen T, Brzoska T, Becher E, Slominski A, Paus R: Cutaneous immunomodulation and coordination of skin stress responses by α-melanocyte-stimulating hormone. Ann NY Acad Sci 1998;840:381-394.
91. Vilches C, Parham P: KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Ann Rev Immunol 2002;20:217-251.
92. Reddehase MJ: Antigens and immunoevasins: opponents in cytomegalievirus immune surveillance. Nat Rev Immunol 2002;2:831-844.
93. Pardoll D: Does the immune system see tumors as foreign or self? Ann Rev Immunol 2003;21:807-839.